Provectus Biopharmaceuticals (Warrant)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PVCTW and buy or sell other stocks, ETFs, and their options commission-free!About PVCTW
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer.
CEOEdward V. Pershing, CPA
CEOEdward V. Pershing, CPA
Employees—
Employees—
HeadquartersKnoxville, Tennessee
HeadquartersKnoxville, Tennessee
Founded2002
Founded2002
Employees—
Employees—
PVCTW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.28K
Average volume2.28K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.018
52 Week high$0.018
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
As of today, Provectus Biopharmaceuticals (Warrant)(PVCTW) shares are valued at $0.01.
On 2025-12-13, Provectus Biopharmaceuticals (Warrant)(PVCTW) stock opened at —, reached a high of —, and a low of —.
The Provectus Biopharmaceuticals (Warrant)(PVCTW)'s current trading volume is 0, compared to an average daily volume of 2.28K.
During the past year, Provectus Biopharmaceuticals (Warrant)(PVCTW) stock moved between $0.00 at its lowest and $0.02 at its peak.
During the past year, Provectus Biopharmaceuticals (Warrant)(PVCTW) stock moved between $0.00 at its lowest and $0.02 at its peak.